INTENDED AUDIENCE

This activity is intended for clinicians who actively treat and/or manage patients with Lennox-Gastaut syndrome.

LEARNING OBJECTIVES

Upon completion of this enduring material, participants should be able to:

• Diagnose Lennox-Gastaut syndrome based on techniques, symptoms, and clinical presentation
• Employ treatment options for patients (AEDs, surgery, VNS) with Lennox-Gastaut syndrome, based on individualized care as the patient ages
• Prescribe appropriate AEDs in patients with Lennox-Gastaut syndrome

ACCREDITATION STATEMENTS

PHYSICIANS
Rush University Medical Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Rush University Medical Center designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

OPINIONS AND OFF-LABEL DISCUSSIONS

Release Date: September 2014 The opinions or views expressed in this educational program are those of the participants and do not necessarily reflect the opinions or recommendations of Eisai, Lundbeck, Rush University Medical Center or Practice Point Communications. The faculty may have included discussion on unlabeled uses of a commercial product or an investigational use of a product not yet approved for this purpose. Please consult the full prescribing information before using any medication mentioned in this program. Expiration Date: September 30, 2016

FACULTY and DISCLOSURES

Michael C. Smith, MD
Director, Rush Epilepsy Center
Professor, Department of Neurological Sciences
Rush University Medical Center

Grant/research support: None
Consultant: None
Speaker's bureau: None
Stock shareholder: None
Other financial or material support: None

John M. Pellock, MD
Senior Associate Dean
Continuing Medical Education
Professor of Neurology and Pediatrics
Division of Child Neurology
Virginia Commonwealth University

Grant/research support: NIH/NINDS, CDC/HRSA, Eisai, Marinus Pharmaceuticals, Lundbeck, Pfizer, Questcor, UCB Pharmaceuticals, Upshur-Smith
Consultant: NIH/NINDS, Acorda, Catalyst, Eisai, GlaxoSmithKline, King Pharmaceuticals, Marinus Pharmaceuticals, Medscape, NeuroPace, Lundbeck, Pfizer, Questcor, Sepracor, Sunovion, UCB Pharmaceuticals, Upshur-Smith, Valeant
Speaker's bureau: Advisory Board: Acorda, Catalyst, Eisai, Medscape, Lundbeck, Pfizer, Questcor, Sepracor, UCB Pharmaceuticals, Upshur-Smith
Stock shareholder: None
Other financial or material support: None

It is the policy of the Rush University Medical Center Office of Interprofessional Continuing Education to ensure that its CE activities are independent, free of commercial bias and beyond the control of persons or organizations with an economic interest in influencing the content of CE. Everyone who is in a position to control the content of an educational activity must disclose all relevant financial relationships with any commercial interest (including but not limited to pharmaceutical companies, biomedical device manufacturers, or other corporations whose products or services are related to the subject matter of the presentation topic) within the preceding 12 months. If there are relationships that create a conflict of interest, these must be resolved by the CE Course Director in consultation with the Office of Interprofessional Continuing Education prior to the participation of the faculty member in the development or presentation of course content.

The remaining planner(s) and reviewer(s) of this activity have no relevant financial relationships to disclose.

RESOLUTION OF CONFLICTS OF INTEREST

In accordance with the ACCME Standards for Commercial Support of CME, Rush University Medical Center and Practice Point Communications will implement mechanisms, prior to the planning and implementation of this CME activity, to identify and resolve conflicts of interest for all individuals in a position to control content of this CME activity.

COPYRIGHT INFORMATION

Any unauthorized use of any materials on the site may violate copyright, trademark, and other laws. You may view, copy, and download information or software ("Materials") found on the site subject to the following terms, conditions, and exceptions: The materials are to be used solely for personal, noncommercial, informational and educational purposes. The materials are not to be modified. They are to be distributed in the format provided with the source clearly identified. The copyright information or other proprietary notices may not be removed, changed, or altered.

Materials may not be published, uploaded, posted, transmitted (other than as set forth herein), without prior written permission.

METHOD OF PARTICIPATION / HOW TO RECEIVE CREDIT

• There are no fees for participating in and receiving credit for this activity
• Review the activity objectives and CME information
• Review the complete expert analysis associated with this course
• Successfully complete the post-test (75% accuracy)
• The estimated time to complete this activity is 1 hour
• Upon successful completion your CME certificate will be available to print the certificate for your records

HARDWARE/SOFTWARE REQUIREMENTS

• Hardware: A minimum of 512MB of RAM and a Pentium IV CPU for Intel-based hardware & PowerPC G4 or above for MAC.
• Graphics/Monitor: A color monitor capable of a minimum of 1024 x 768 pixel resolution
• Network: An Internet connection with 1Mbps available download & 256kbps bandwidth

• Windows XP or above running Internet Explorer 7 (service pack 2) or above.
• MAC OSX 10.5 (Leopard) or above running Safari 5.1 or above, or any version of Chrome, Firefox or Opera published in the last two years.
• A recent version of a Linux distribution or FreeBSD running Chrome v13, Opera 11.5, Firefox 5.0.1, or Epiphany 3.0.4 or above

• Any Apple iPad or iPad Mini running IOS 5 or above.
• Most high-performance Android tablets such as the Kindle Fire or Samsung Galaxy S

COMMERCIAL SUPPORT ACKNOWLEDGMENT